Table 6.
Average asthma severity 0–12 months: Subgroup and sensitivity analyses (SA)
| Group/Analysis | N |
0 months |
12 months |
T-test: 0–12 month difference |
|
|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (95% CI) | P-value | ||
| Main analysis: Patients with available data at 0 and 12 months | 66 | 5.35 (2.17) | 2.74 (2.30) | 2.61 (1.90–3.32) | <0.001 |
| Age groups | |||||
| • Children (2–16 years) | 29 | 5.69 (2.24) | 2.14 (2.07) | 3.55 (2.45–4.65) | <0.001 |
| • Adults (17–70 years) | 37 | 5.08 (2.11) | 3.22 (2.39) | 1.86 (0.96–2.76) | <0.001 |
| Main anthroposophic therapy modality | |||||
| • Medical | 37 | 5.35 (2.15) | 2.35 (1.99) | 3.00 (2.17–3.83) | <0.001 |
| • Eurythmy therapy, art therapy, or rhythmical massage therapy | 29 | 5.34 (2.24) | 3.24 (2.60) | 2.10 (0.84–3.37) | 0.002 |
| • Eurythmy therapy | 21 | 5.19 (2.36) | 3.14 (2.63) | 2.05 (0.57–3.53) | 0.009 |
| Number of patients enrolled per physician | |||||
| • 1–5 patients (30 physicians) | 44 | 5.43 (2.14) | 2.98 (2.34) | 2.45 (1.52–3.39) | <0.001 |
| • 36 patients (one physician) | 22 | 5.18 (2.28) | 2.27 (2.21) | 2.91 (1.80–4.02) | <0.001 |
| SA1: Last value carried forward | 89 | 5.48 (2.14) | 3.20 (2.51) | 2.28 (1.69–2.87) | <0.001 |
| SA2: Patients not using asthma medications apart from adrenergic inhalants, and not having asthma-related surgery in months 0–12 | 28 | 5.93 (2.05) | 3.39 (2.77) | 2.54 (1.26–3.81) | <0.001 |
| SA1 + SA2 | 28 | 5.93 (2.05) | 3.39 (2.77) | 2.54 (1.26–3.81) | <0.001 |
Abbreviations: CI, confidence interval; SD, standard deviation.